R1 RCM Inc
NASDAQ:RCM
R1 RCM Inc
NASDAQ:RCM
Price:
12.36 USD
0.57%
Market Closed
Updated:
May 2, 2024
R1 RCM Inc
Revenue
|
R1 RCM Inc
Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
R1 RCM Inc
NASDAQ:RCM
|
Revenue
$2.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
R1 RCM Inc
Revenue Breakdown
Breakdown by Geography
R1 RCM Inc
R1 RCM Inc
Not Available
Breakdown by Segments
R1 RCM Inc
R1 RCM Inc
|
Total Revenue:
2.3B
USD
|
|
Net Operating Fees:
1.5B
USD
|
|
Modular And Other Fees:
689.9m
USD
|
|
Incentive Fees:
108.4m
USD
|
See Also
What is R1 RCM Inc's Revenue?
Revenue
2.3B
USD
2.3B
USD
Based on the financial report for Dec 31, 2023, R1 RCM Inc's Revenue amounts to 2.3B USD.
What is R1 RCM Inc's Revenue growth rate?
Revenue CAGR 10Y
16%
16%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for R1 RCM Inc have been 21% over the past three years , 21% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
